儿童肺动脉高压危象当前管理的光谱
本研究为电子横断面调查,覆盖美国和加拿大99所被识别机构中的PICU,应答率50%。应答者82.2%为大型PICU的儿科重症主治医师,73.9%有超过十年培训后经验,中位每年管理10例急性肺动脉高压危象患者。61.1%机构有正式超声心动图方案但内容不一,心导管检查无一致指征;所有机构使用吸入一氧化氮,肠内磷酸二酯酶5抑制剂是最常用附加靶向血管扩张治疗,米力农和肾上腺素是最常用血管活性输注,机械通气无首选方案,芬太尼和右美托咪定为首选镇静输注,51.1%机构有正式肺动脉高压会诊团队。作者认为结果可为正式推荐提供参考,尤其关于团队构成和肺血管扩张治疗,北美指南目前缺乏,需进一步研究确定最佳实践和标准化。
要点
- 所有应答机构均使用吸入一氧化氮治疗儿童肺动脉高压危象,肠内磷酸二酯酶5抑制剂是最常用的附加靶向血管扩张治疗。
- 米力农和肾上腺素是儿童肺动脉高压危象最常用的血管活性输注药物。
- 芬太尼和右美托咪定是首选镇静输注药物。
- 61.1%机构有正式超声心动图方案但内容不一;心导管检查在肺动脉高压危象入院期间无一致指征。
- 51.1%机构有正式肺动脉高压会诊团队,最常见人员为儿科心脏病医师、儿科肺病医师和高级实践护士。
适用人群与场景
- 北美PICU中表现为急性肺动脉高压危象的儿童。
- 调查对象为美国和加拿大PICU的 faculty members。
处置流程与药物剂量
- 所有应答机构使用吸入一氧化氮。
- 肠内磷酸二酯酶5抑制剂是最常用的附加靶向血管扩张治疗。
- 米力农和肾上腺素是最常用的血管活性输注药物。
- 芬太尼和右美托咪定是首选的镇静输注药物。
- 机械通气无首选方法。
- 61.1%机构有正式超声心动图方案,但所报告内容不一。
- 肺动脉高压危象入院期间心导管检查无一致指征。
- 51.1%机构报告有正式肺动脉高压会诊团队,最常见人员为儿科心脏病医师、儿科肺病医师和高级实践护士。
研究设计与关键结果
- 研究类型为电子横断面调查,覆盖美国和加拿大99所被识别机构中的PICU,应答率50%。
- 应答者82.2%为来自大型PICU的儿科重症主治医师,73.9%有超过十年培训后经验。
- 应答者中位每年管理10例急性肺动脉高压危象患者。
- 61.1%机构有正式超声心动图方案,但所报告内容不一。
- 所有机构使用吸入一氧化氮,肠内磷酸二酯酶5抑制剂是最常用的附加靶向血管扩张治疗。
- 米力农和肾上腺素是最常用的血管活性输注药物;机械通气无首选方法。
- 芬太尼和右美托咪定是首选的镇静输注药物;51.1%机构有正式肺动脉高压会诊团队。
证据类型、等级与局限
- 证据类型为电子横断面调查。
- 局限:北美指南目前缺乏。
- 局限:需要额外工作来确定最佳实践、实践标准化及其对结局的影响。
对床旁实践的改变
- 调查显示儿童急性肺动脉高压危象的管理多样,无统一方案。
- 作者认为调查结果可为正式推荐提供参考,尤其关于照护团队构成和肺血管扩张治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Pulmonary hypertension is a growing pediatric problem and children may present with pulmonary hypertensive crisis-a life-threatening emergency requiring acute interventions. The aim of this study was to characterize the broad spectrum of care provided in North American PICUs for children who present with pulmonary hypertensive crisis.
DESIGN: Electronic cross-sectional survey. Survey questions covered the following: demographics of the respondents, institution, and patient population; pulmonary hypertension diagnostic modalities; pulmonary hypertension-specific pharmacotherapies; supportive therapies, including sedation, ventilation, and inotropic support; and components of multidisciplinary teams.
SETTING: PICUs in the United States and Canada.
SUBJECTS: Faculty members from surveyed institutions.
INTERVENTIONS: None.
MEASUREMENT AND MAIN RESULTS: The response rate was 50% of 99 identified institutions. Of the respondents, 82.2% were pediatric intensivists from large units, and 73.9% had over a decade of experience beyond training. Respondents provided care for a median of 10 patients/yr with acute pulmonary hypertensive crisis. Formal echocardiography protocols existed at 61.1% of institutions with varying components reported. There were no consistent indications for cardiac catheterization during a pulmonary hypertensive crisis admission. All institutions used inhaled nitric oxide, and enteral phosphodiesterase type 5 inhibitor was the most frequently used additional targeted vasodilator therapy. Milrinone and epinephrine were the most frequently used vasoactive infusions. Results showed no preferred approach to mechanical ventilation. Fentanyl and dexmedetomidine were the preferred sedative infusions. A formal pulmonary hypertension consulting team was reported at 51.1% of institutions, and the three most common personnel were pediatric cardiologist, pediatric pulmonologist, and advanced practice nurse.
CONCLUSIONS: The management of critically ill children with acute pulmonary hypertensive crisis is diverse. Findings from this survey may inform formal recommendations - particularly with regard to care team composition and pulmonary vasodilator therapies - as North American guidelines are currently lacking. Additional work is needed to determine best practice, standardization of practice, and resulting impact on outcomes.
参考来源
- Bernier ML, Romer LH, Bembea MM, et al. Spectrum of Current Management of Pediatric Pulmonary Hypertensive Crisis. Crit Care Explor. 2019. PMID: 32166278. doi:10.1097/CCE.0000000000000037
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。